News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
SINO BIOPHARM (01177.HK) Plans to Launch 5 Innovative Products Annually Over Next 3 Yrs, Expects Landmark Out-Licensing Deal Soon
SINO BIOPHARM (01177.HK) announced that the proportion of revenue from the Group’s innovative products has risen from 16% in 2018 to 42% in 2024, with expectations to exceed ...
Reset
Send
The window will close in 5 seconds
SINO BIOPHARM (01177.HK) Plans to Launch 5 Innovative Products Annually Over Next 3 Yrs, Expects Landmark Out-Licensing Deal Soon
Close
Recommend
34
Positive
64
Negative
19
 
 

SINO BIOPHARM (01177.HK)  -0.160 (-2.812%)    Short selling $176.68M; Ratio 8.168%   announced that the proportion of revenue from the Group’s innovative products has risen from 16% in 2018 to 42% in 2024, with expectations to exceed 50% in 2025, marking a successful milestone in the Group’s innovation transformation.

Over the next three years, the Group plans to launch around five innovative products annually, aiming to further increase the proportion of revenue from innovative products to 60% by 2027. This growth momentum is largely driven by the Group’s dual-engine strategy of “in-house R&D + business development (BD)”.

Related NewsCLSA: Biotech Stocks Largely Complete 1st Phase of Valuation Recovery; Liquidity & Fundamentals Expected to Improve
The Group has announced 12 innovative products with breakthrough data (including four Late-Breaking Abstracts (LBA)) at the American Society of Clinical Oncology (ASCO) Annual Meeting, achieving a major breakthrough.

Since the beginning of this year, out-licensing has become one of the Group’s most critical strategic priorities, and an out-licensing deal is expected to be finalized soon.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-13 16:25.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.